Home
>
National Drug Code (NDC)
>
Ontak
Ontak - 62856-603-01 - (denileukin diftitox)
Drug Information of Ontak
| Product NDC: | 62856-603 |
| Proprietary Name: | Ontak |
| Non Proprietary Name: | denileukin diftitox |
| Active Ingredient(s): | 150 ug/mL & nbsp; denileukin diftitox |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ontak
| Product NDC: | 62856-603 |
| Labeler Name: | Eisai Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103767 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20081015 |
Package Information of Ontak
| Package NDC: | 62856-603-01 |
| Package Description: | 6 VIAL, SINGLE-USE in 1 PACKAGE (62856-603-01) > 2 mL in 1 VIAL, SINGLE-USE |
NDC Information of Ontak
| NDC Code | 62856-603-01 |
| Proprietary Name | Ontak |
| Package Description | 6 VIAL, SINGLE-USE in 1 PACKAGE (62856-603-01) > 2 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 62856-603 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | denileukin diftitox |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20081015 |
| Marketing Category Name | BLA |
| Labeler Name | Eisai Inc. |
| Substance Name | DENILEUKIN DIFTITOX |
| Strength Number | 150 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | CD25-directed Cytotoxin [EPC],Diphtheria Toxin [Chemical/Ingredient],Interleukin-2 [Chemical/Ingredient],Recombinant Fusion Proteins [Chemical/Ingredient] |
